Numerous drugs are available to treat asthma presently, including β2-adrenoceptor agonists, corticosteroids, and monoclonal antibodies targeting key cytokines (i.e., IL-5, IL-13, and IL-4) (Pedersen et al. 2011; Koski and Grzegorczyk 2020). Here, IL13 is linked to asthma.